HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Braces For Impact Of REACH As Legislation Nears Passage

This article was originally published in The Rose Sheet

Executive Summary

The European Parliament is set to vote on - and likely pass - the Registration, Evaluation, Authorization & Restriction of Chemicals legislation on Dec. 13, according to industry observers

You may also be interested in...



Beauty Firms Should Act Now To Obviate Legislation Later, Lauder VP Says

Openness and consumer engagement are needed from the personal-care industry to assuage the public's fears and stave off further regulation like the costly Registration, Evaluation, Authorization and Restriction of Chemicals program in Europe, according to Estee Lauder's Harvey Gedeon

Beauty Firms Should Act Now To Obviate Legislation Later, Lauder VP Says

Openness and consumer engagement are needed from the personal-care industry to assuage the public's fears and stave off further regulation like the costly Registration, Evaluation, Authorization and Restriction of Chemicals program in Europe, according to Estee Lauder's Harvey Gedeon

REACH Passes European Parliament, Heads For Council And June ’07 Start

The European Parliament (EP) adopted the Registration, Evaluation Authorization & Restriction of Chemicals legislation Dec. 13 by a vote of 529 in favor, 98 against and 24 abstentions

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel